Latest Regulatory Engagement News

Page 3 of 24
Dimerix has secured full sponsorship of the US Investigational New Drug application for its Phase 2-ready kidney drug DMX-652, setting the stage for a clinical trial targeting acute kidney injury in late 2026.
Ada Torres
Ada Torres
17 Aug 2026
Archer Materials has pinpointed a capillary blood collection method that matches venous samples in haemolysis levels, advancing its potassium Biosensor development towards integrated clinical testing.
Sophie Babbage
Sophie Babbage
13 Aug 2026
Metallium Limited has appointed key board members and executives to strengthen governance and operational capacity as it advances its Flash Joule Heating technology towards commercialisation in the US.
Maxwell Dee
Maxwell Dee
10 Aug 2026
AdAlta’s lead CAR-T therapy EW-001 continues to demonstrate encouraging survival and response rates in its mesothelioma study, with all patients alive at the latest follow-up and stronger outcomes at higher doses supporting plans for an Australian Phase 1 trial.
Ada Torres
Ada Torres
10 Aug 2026
American Tungsten & Antimony plans to restart and expand the Del Sol Refinery and White Spar Mine in the US, contingent on completing their acquisition. The company is preparing for increased processing capacity and new product lines while engaging with regulators and engineering firms.
Maxwell Dee
Maxwell Dee
6 Aug 2026
Strata Minerals is pushing forward multiple technical workstreams at its Zelica Gold Project in Western Australia, backed by BML Ventures. These initiatives aim to de-risk mine planning, processing, and permitting as the project moves closer to development.
Maxwell Dee
Maxwell Dee
5 Aug 2026
Neurotech International has secured $4.5 million through a share placement to fund its pivotal Phase III clinical trial of NTI164 for Autism Spectrum Disorder, aiming to reach topline data readout.
Ada Torres
Ada Torres
4 Aug 2026
Hot Chili Limited expands its Costa Fuego copper-gold project with significant drilling success at La Verde, underpinning a strong Preliminary Feasibility Study and strategic water infrastructure plans.
Maxwell Dee
Maxwell Dee
4 Aug 2026
Berkeley Energia has reported a maiden inferred lithium and rubidium resource at its Conchas Project in Spain, alongside appointing former Endesa CEO José Bogas Gálvez to its board, while continuing a US$1.25 billion arbitration against Spain over its Salamanca uranium project.
Maxwell Dee
Maxwell Dee
30 July 2026
Avecho Biotechnology has secured a unanimous recommendation to continue its Phase III insomnia trial without increasing sample size, alongside raising $1.9 million through option exercises and bolstering its cash position to $6.6 million.
Ada Torres
Ada Torres
29 July 2026
AdAlta has completed a key US$1 million milestone payment securing rights to its lead CAR-T therapy EW-001 outside Greater China, progressed Australian manufacturing with first runs expected late 2026, and is preparing for a critical pre-IND meeting with the US FDA.
Ada Torres
Ada Torres
29 July 2026
LTR Pharma’s SPONTAN shows rapid absorption in Phase II interim data while securing key US commercial deals for ROXUS, setting the stage for a US market entry later this year.
Victor Sage
Victor Sage
28 July 2026

Browse the archive

Full archive